A treatment perspective of Jaundice with Cholecystitis in Ayurveda: A case report
DOI:
https://doi.org/10.70066/jahm.v13i8.2239Keywords:
Key words: Jaundice, Cholecystitis, Kosthashrita Kamala, Case reportAbstract
Background: Kamala refers to a disease condition where there will be yellowish discoloration of eyes, skin and urine along with other specific symptoms. Kosthashrita Kamala and Shakhashrita Kamala are the two types of Kamala according to Ayurveda classics. The obstructive pathology of Jaundice resembles the samprapti of Shakhashrita kamala and non-obstructive pathology to Kosthashrita kamala. Cholecystitis, the inflammation of wall of Gall bladder, most likely occurs due to Cholelithiasis, that is presence of gall stones with partial or complete obstruction of cystic duct or common bile duct. Jaundice is the most predominant sign in this condition. Surgery is considered as the only and ultimate treatment in the condition of Acute Cholecystitis by alternate system of medicine. Clinical findings: The present case report deals with a case of Kosthashrita kamala where the patient was having acute pain abdomen, jaundice, reddish discoloration of urine along with fever, nausea and vomiting. Investigations revealed raised values of LFT and Ultrasound of abdomen revealed Cholecystitis and Cholelithiasis without any obstruction to cystic or common bile ducts. Outcome: The symptoms were assessed and graded along with the blood investigations. Patient was treated with only oral medication and diet, under appropriate monitoring. Both subjective and objective parameters showed significant difference after the treatment within a short duration of time. Conclusion: This case report sets an example to accentuate the role of Ayurvedic rational treatment protocols in treating even acute disease conditions like Cholecystitis.
References
R Alagappan, Manual of Practical Medicine, 7th ed, New Delhi, Jaypee Brothers Medical Publishers, re-print 2024, p 366.
Agnivesha, Charaka, Drudabala, Chakrapanidatta. Sutra Sthana, Chapter 19 Astodariya adhyaya, Verse. 4(7). In: Acharya YT (Edi.), Charaka Samhita with Ayurveda Deepika Commentary. Reprint Edition: 2019. Varanasi: Chaukhamba Orientalia: 2019. p.111.
Agnivesha, Charaka, Drudabala, Chakrapanidatta. Chikitsa Sthana, Chapter Panduroga Chikitsa, Verse. 124. In: Acharya YT (Edi.), Charaka Samhita with Ayurveda Deepika Commentary. Reprint Edition: 2019. Varanasi: Chaukhamba Orientalia: 2019. p.532.
Agnivesha, Charaka, Drudabala, Chakrapanidatta. Chikitsa Sthana, Chapter Panduroga Chikitsa, Verse. 35. In: Acharya YT (Edi.), Charaka Samhita with Ayurveda Deepika Commentary. Reprint Edition: 2019. Varanasi: Chaukhamba Orientalia: 2019. p.528.
Ralston, Stuart H., Ian D. Penman, Mark W. J. Strachan, and Richard Hobson, eds. 2023. Davidson’s Principles and Practice of Medicine. 24rd ed. London, England: Elsevier Health Sciences.
Kasper DL, Fauci AS, Hauser S, et al, editors. Harrison’s principles of internal medicine, 19th ed. New York: The McGraw-Hill Companies, Inc.; 2015. P 281.
Varsakiya J, Goyal M, Kumari R, Kathad D. Role of Ayurveda treatment in the management of hepatitis B (Ubhayapatha Ashrita Swatantra Kamala)- A case report. Ayu. 2022 Jan-Mar;43(1):13-17. doi: 10.4103/ayu.ayu_17_21. Epub 2023 Jun 24. PMID: 37554413; PMCID: PMC10405884.
Kashyap Samhita, edited by Shri Satyapal Bhishagacharya with hindi commentary Vidyotini, Reprint 2018, Choukhmbha Sanskrit Series, Varanasi, Khila sthana 2/50, p 359.
Vagbhata, Arunadatta, Hemadri. Sutra sthana, Chapter Shodhanadigana sangram adhyaya, Verse. 15. In: Pt. Hari Sadashiva Shastri Paradakara Bhishagacharya (Edi.), Ashtanga Hridaya with Sarvanga Sundara and Ayurveda Rasayana Commentary. Reprint Edition: 2019. Varanasi: Chaukhamba Subharti Prakashana: 2019. p.235.
Vidyasagar PS, editor. Prathamakhanda 4, Verse 5. In: Sharangadhara’s Sharangadhara Samhita with Sanskrit Commentary. Varanasi: Chaukhambha Orientalia; Re-print ed 2018. p.139
Rasa Vaghbhata, Rasa Ratna Samucchaya, 7th Edn ,20th chapter , shloka 87-93, Commentry by Ambika Datta Shastri, Choukhambha Sanskrit series, Varanasi ; 400.
Vaidya Lakshmipati Shastri, Hindi commentary, Yogaratnakar with vidyotini Hindi commentary, Uttarardha, Amlapitta chikitsa, Varanasi, chaukambha Sanskrit Sansthanhan, 2018, p. 244
Kantharia, Chetan & Kumar, Munesh & Jain, Mukesh & Sharma, Lokendra & Jain, Lokesh & Desai, Anish. (2023). Hepatoprotective Effects of Liv.52 in Chronic Liver Disease Preclinical, Clinical, and Safety Evidence: A Review. Gastroenterology Insights. 14. 293-308. 10.3390/gastroent14030021.
Vaidya Lakshmipati Shastri, Hindi commentary, Yogaratnakara with vidyotini Hindi commentary, Panduroga chikitsa, verse no 72 (17), Varanasi, Chaukambha Sanskrit Sansthanhan, 2018, p. 345.
Agnivesha, Charaka, Drudabala, Chakrapanidatta. Sutra Sthana, Annapanavidhimadhyaya, Verse. 218. In: Acharya YT (Edi.), Charaka Samhita with Ayurveda Deepika Commentary. Reprint Edition: 2019. Varanasi: Chaukhamba Orientalia: 2019. p.165.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 S Shreelakshmi, Harshitha K S

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.